Package Leaflet: Information for the User
Fareston 60 mg Tablets
toremifene
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
5 Storage of Fareston
Fareston contains the active substance toremifene, an anti-estrogen. Fareston is indicated for the treatment of certain types of breast tumors in women after menopause.
Do not take Fareston
This is because Fareston can affect your heart by causing a delay in the electrical signals in your heart (prolongation of the QT interval).
Warnings and precautions
Talk to your doctor or pharmacist before starting Fareston.
You should have gynecological examinations at the start of treatment with Fareston and at least once a year while you are taking Fareston. Your doctor will perform regular checks if you have high blood pressure, diabetes, have undergone hormone replacement therapy, or if you are obese (BMI over 30).
Other medicines and Fareston
Tell your doctor if you are taking, have recently taken, or might take any other medicines. It may be necessary to adjust the dose of one of them while you are taking Fareston. In particular, tell your doctor if you are taking any of the following medicines:
Do not take Fareston with the following medicines as there is a risk of altering your heart rhythm (see section 2 "Do not take Fareston"):
If you are admitted to hospital or prescribed a new medicine, tell your doctor that you are taking Fareston.
Pregnancy and breastfeeding
Do not take Fareston during pregnancy or breastfeeding.
Driving and using machines
Fareston has no influence on the ability to drive and use machines.
Fareston contains lactose
It contains 28.5 mg of lactose (as monohydrate) per tablet. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Other excipients
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Follow exactly the instructions of administration of this medicine given to you by your doctor. If you are in doubt, consult your doctor or pharmacist again. The recommended dose is one 60 mg tablet per day, taken orally. Fareston can be taken with or without food.
If you take more Fareston than you should
Contact your doctor, pharmacist, or the nearest hospital immediately. The symptoms of overdose may be dizziness and headache.
If you forget to take Fareston
If you forget to take a dose, take the next tablet as usual and continue the treatment as recommended. Do not take a double dose to make up for forgotten doses. If you forget several doses, inform your doctor and follow their instructions.
If you stop taking Fareston
Treatment with Fareston should only be stopped when your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
endometrial cancer
Frequency not known (cannot be estimated from the available data)
(leukopenia)
You should contact your doctor immediately if you notice any of the following symptoms:
Fareston causes certain abnormal changes in the electrical activity of the heart (electrocardiogram or ECG). See section 2 "Warnings and precautions".
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Annex V.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Fareston
Appearance and packaging
The tablets are white, round, smooth, beveled, with TO 60 printed on one side.
30 and 100 tablets. Some pack sizes may not be marketed.
Marketing authorization holder
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Manufacturer
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
You can obtain more information on this medicine by contacting the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien Orion Corporation Tel: +358 10 4261 | Lithuania Orion Corporation Tel: +358 10 4261 |
Bulgaria Orion Pharma Poland Sp. z o.o. Tel: + 48 22 8 333 177 | Luxembourg/Luxemburg Orion Corporation Tel: +358 10 4261 |
Czech Republic Orion Corporation Tel: +358 10 4261 | Hungary Orion Corporation Tel: +358 10 4261 |
Denmark Orion Corporation Tel: +358 10 4261 | Malta Orion Corporation Tel: +358 10 4261 |
Germany Orion Corporation Tel: +358 10 4261 | Netherlands Orion Corporation Tel: +358 10 4261 |
Estonia Orion Corporation Tel: +358 10 4261 | Norway Orion Corporation Tel: +358 10 4261 |
Greece Orion Corporation Tel: +358 10 4261 | Austria Orion Corporation Tel: +358 10 4261 |
Spain Orion Corporation Tel: +358 10 4261 | Poland Orion Corporation Tel: +358 10 4261 |
France Orion Pharma Tel: +33 (0) 1 85 18 00 00 | Portugal Orion Corporation Tel: +358 10 4261 |
Croatia Orion Corporation Tel: +358 10 4261 | Romania Orion Pharma Poland Sp. z o.o. Tel: + 48 22 8 333 177 |
Ireland Orion Corporation Tel: +358 10 4261 | Slovenia Orion Corporation Tel: +358 10 4261 |
Iceland Orion Corporation Tel: +358 10 4261 | Slovakia Orion Corporation Tel: +358 10 4261 |
Italy Orion Pharma S.r.l. Tel: + 39 02 67876111 | Finland Orion Corporation Tel: +358 10 4261 |
Cyprus Orion Corporation Tel: +358 10 4261 | Sweden Orion Pharma AB Tel: +46 8 623 6440 |
Latvia Orion Corporation Tel: +358 10 4261 | United Kingdom (Northern Ireland) Orion Corporation Tel: + 358 10 4261 |
Date of last revision of this leaflet:
Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu